CIRM names CEO, funds additional clinics and trials

California Institute for Regenerative Medicine named Maria Millan CEO and president. She was interim CEO and president and VP of therapeutics, and will succeed President Randal Mills, who left in June.

CIRM also said it is providing $16 million to establish two additional Alpha Stem Cell Clinics -- medical centers which perform stem cell trials -- at the University of California Davis and UC San Francisco...